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Liver or bone marrow transplantation has been unsuccessful in the treatment of 
NPA and NPC. 
Enzyme replacement therapy is being developed for patients with NPB who 
have no neurologic symptoms. 
No evidence indicates that climethyl sulfazixe or cholesterol.
Lowering agents improve neurologic symptoms in NPC.
Reliable parental diagnosis uses Molecular investigations on chrionic DNA 
when familial mutations have been clearly defined.
No specific treatment is available for NPA. 
Cataplexy could be improved by clomipramine or modafinal.
The following reports illustraye yhe range of experimental therapied for NDP: 
•  Hematopoietic  stem cell transplantation(HSCT) did not modify the 
neurological course.
• Retroviral mediated transfer using acid sphingomyelinase (ASM) cDNa in 
cultured fibroblasts of affected patients resulted in up to 2 16 fold increase 
in ASM activity. 
• Direct intracerebral transplant of neural progenitor cells into the mouse 
model of NDP-A.
• Treatment with tamoxifen in combination with vitamin E, Did not have 
significant effect in the mouse model of NPD-C.
• Another approach is based on the observation that neursteroids, made in the 
central nervous system.
• Neurosteroidogenesis and treatment with allopreganolane in the NPD-C 
mouse delayed neurological symptoms.
• Bone marrow-derives mesenchymal stem cells in NPC-C mice suppressed 
neurogical inflammation and resduced cerebellar pathology.
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